XML 54 R34.htm IDEA: XBRL DOCUMENT v3.24.1

Consolidated Statements of Operations and Comprehensive Loss (Details) - Schedule of Weighted Average	12 Months Ended
	Dec. 31, 2023 € / shares shares	Dec. 31, 2023 $ / shares shares	Dec. 31, 2022 € / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 € / shares shares	Dec. 31, 2021 $ / shares shares
2021
Options (in Shares) | shares	1,735,750	1,735,750	1,966,666	1,966,666	1,219,074	1,219,074
January 4 [Member]
2021
Options (in Shares) | shares					839,260	839,260
Fair value per option						$ 4.53
FX rate as of grant date						$ 0.8133
Fair value per option (in Euro per share) | € / shares					€ 3.68
Expected volatility					1.35%	1.35%
Expected life (midpoint based)					5 years 3 months 21 days	5 years 3 months 21 days
Risk-free rate (interpolated, U.S. sovereign strips curve)					0.50%	0.50%
January 4 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price						$ 5.14
January 4 [Member]
2021
Options (in Shares) | shares					31,668	31,668
Fair value per option						$ 4.57
FX rate as of grant date						$ 0.8133
Fair value per option (in Euro per share) | € / shares					€ 3.72
Expected volatility					1.35%	1.35%
Expected life (midpoint based)					5 years 6 months	5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)					0.50%	0.50%
January 4 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price						$ 5.14
July 2 [Member]
2021
Options (in Shares) | shares					327,436	327,436
Fair value per option						$ 2.64
FX rate as of grant date						$ 0.8458
Fair value per option (in Euro per share) | € / shares					€ 2.23
Expected volatility					1.35%	1.35%
Expected life (midpoint based)					5 years 3 months 21 days	5 years 3 months 21 days
Risk-free rate (interpolated, U.S. sovereign strips curve)					0.98%	0.98%
July 2 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price						$ 2.99
July 2 [Member]
2021
Options (in Shares) | shares					20,710	20,710
Fair value per option						$ 2.66
FX rate as of grant date						$ 0.8458
Fair value per option (in Euro per share) | € / shares					€ 2.25
Expected volatility					1.35%	1.35%
Expected life (midpoint based)					5 years 5 months 26 days	5 years 5 months 26 days
Risk-free rate (interpolated, U.S. sovereign strips curve)					1.01%	1.01%
July 2 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price						$ 2.99
January 12 [Member]
2021
Options (in Shares) | shares			1,516,666	1,516,666
Fair value per option				$ 3.66
FX rate as of grant date				$ 0.8795
Fair value per option (in Euro per share) | € / shares			€ 3.22
Expected volatility			1.35%	1.35%
Expected life (midpoint based)			5 years 3 months 21 days	5 years 3 months 21 days
Risk-free rate (interpolated, U.S. sovereign strips curve)			1.57%	1.57%
January 12 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price				$ 4.13
January 12 [Member]
2021
Options (in Shares) | shares			45,000	45,000
Fair value per option				$ 3.68
FX rate as of grant date				$ 0.8795
Fair value per option (in Euro per share) | € / shares			€ 3.24
Expected volatility			1.35%	1.35%
Expected life (midpoint based)			5 years 6 months	5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)			1.59%	1.59%
January 12 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price				$ 4.13
Repricing, April 13 [Member]
2021
Options (in Shares) | shares
FX rate as of grant date				$ 0.9237
Expected volatility			1.35%	1.35%
Risk-free rate (interpolated, U.S. sovereign strips curve)			2.60%	2.60%
Repricing, April 13 [Member] | Bottom of range [Member]
2021
Fair value per option				$ 1.2
Fair value per option (in Euro per share) | € / shares			€ 1.11
Share price at grant date / Exercise price				$ 1.86
Expected life (midpoint based)			1 year 9 months 29 days	1 year 9 months 29 days
Repricing, April 13 [Member] | Top of range [Member]
2021
Fair value per option				$ 1.63
Fair value per option (in Euro per share) | € / shares			€ 1.5
Expected life (midpoint based)			4 years 11 months 8 days	4 years 11 months 8 days
November 21 [Member]
2021
Options (in Shares) | shares			405,000	405,000
Fair value per option				$ 2.04
FX rate as of grant date				$ 0.976
Fair value per option (in Euro per share) | € / shares			€ 1.99
Expected volatility			1.35%	1.35%
Expected life (midpoint based)			4 years	4 years
Risk-free rate (interpolated, U.S. sovereign strips curve)			4.15%	4.15%
November 21 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price				$ 2.44
January 24 [Member]
2021
Options (in Shares) | shares	1,454,250	1,454,250
Fair value per option		$ 2.11
FX rate as of grant date		$ 0.9008
Fair value per option (in Euro per share) | € / shares	€ 1.9
Expected volatility	1.35%	1.35%
Expected life (midpoint based)	5 years 3 months 18 days	5 years 3 months 18 days
Risk-free rate (interpolated, U.S. sovereign strips curve)	3.571%	3.571%
January 24 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price		$ 2.37
January 24 [Member]
2021
Options (in Shares) | shares	52,500	52,500
Fair value per option		$ 2.13
FX rate as of grant date		$ 0.9008
Fair value per option (in Euro per share) | € / shares	€ 1.92
Expected volatility	1.35%	1.35%
Expected life (midpoint based)	5 years 6 months	5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)	3.565%	3.565%
January 24 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price		$ 2.37
May 31 [Member]
2021
Options (in Shares) | shares	60,500	60,500
Fair value per option		$ 3.61
FX rate as of grant date		$ 0.9361
Fair value per option (in Euro per share) | € / shares	€ 3.38
Expected volatility	1.35%	1.35%
Expected life (midpoint based)	4 years 6 months	4 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)	3.82%	3.82%
May 31 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price		$ 4.19
July 7 [Member]
2021
Options (in Shares) | shares	57,000	57,000
Fair value per option		$ 3.59
FX rate as of grant date		$ 0.9184
Fair value per option (in Euro per share) | € / shares	€ 3.3
Expected volatility	1.46%	1.46%
Expected life (midpoint based)	5 years 6 months	5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)	4.32%	4.32%
July 7 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price		$ 3.89
July 7 [Member]
2021
Options (in Shares) | shares	100,000	100,000
Fair value per option		$ 3.64
FX rate as of grant date		$ 0.9184
Fair value per option (in Euro per share) | € / shares	€ 3.34
Expected volatility	1.46%	1.46%
Expected life (midpoint based)	6 years 1 month 6 days	6 years 1 month 6 days
Risk-free rate (interpolated, U.S. sovereign strips curve)	4.286%	4.286%
July 7 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price		$ 3.89
July 19 [Member]
2021
Options (in Shares) | shares	4,000	4,000
Fair value per option		$ 3.55
FX rate as of grant date		$ 0.8911
Fair value per option (in Euro per share) | € / shares	€ 3.16
Expected volatility	1.46%	1.46%
Expected life (midpoint based)	5 years 6 months	5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)	4.32%	4.32%
July 19 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price		$ 3.99
September 18 [Member]
2021
Options (in Shares) | shares	7,500	7,500
Fair value per option		$ 3.15
FX rate as of grant date		$ 0.9378
Fair value per option (in Euro per share) | € / shares	€ 2.95
Expected volatility	1.46%	1.46%
Expected life (midpoint based)	5 years 6 months	5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)	4.32%	4.32%
September 18 [Member] | Bottom of range [Member]
2021
Share price at grant date / Exercise price		$ 3.54

X

- Definition

The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The fair value option per share.

+ References

No definition available.

+ Details

Name:	ifrx_FairValuePerOptions
Namespace Prefix:	ifrx_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The fair value per option.

+ References

No definition available.

+ Details

Name:	ifrx_FairValuesPerOptions
Namespace Prefix:	ifrx_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The foreign exchange rate as grant date.

+ References

No definition available.

+ Details

Name:	ifrx_ForeignExchangeRateAsOfGrantDate
Namespace Prefix:	ifrx_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Share options granted options.

+ References

No definition available.

+ Details

Name:	ifrx_ShareOptionsGrantedOptions
Namespace Prefix:	ifrx_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The share price at grant date and exercise price.

+ References

No definition available.

+ Details

Name:	ifrx_SharePriceAtGrantDateExercisePrices
Namespace Prefix:	ifrx_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrx_a2021Abstract
Namespace Prefix:	ifrx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January4Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January4OneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_July2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_July2OneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January12Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January12OneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_RepricingApril13Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_November21Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryTwentyFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryTwentyFourOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_MayThirtyOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulySevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulySevenOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulyNineteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_SeptemberEighteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: